Golden Rules Beta Skin
Natural health product licensed in Canada
- Other names
- Golden Formulas Beta Skin, Seven Medallion Beta Skin
- Licence holder
- Golden Rules Medical Inc.
- NPN or DIN-HM
- 80051330
- Status
- Active licence
- Licence date
- 2 June 2014
- Revision date
- 27 June 2014
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Punica granatum Source : Punica granatum, Fruit | 20 mg | Not calculated |
| Myo-Inositol Source : Inositol | 50 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 50 mg | Not calculated |
| Vitis vinifera Source : Vitis vinifera - Graine Extraction ratio : 4:1 Dry plant equivalent : 400 mg Potency : 85 % Oligomeric proanthocyanidins | 100 mg | Not calculated |
Non-medicinal ingredients
Huile de fève de soja, Lécithine de soja enrichie en phosphatidylsérine, Dioxyde de titane, Caramel, Cire d'abeille, Gélatine, Eau purifiée, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of antioxidants for the maintenance of good health. Helps to relieve symptoms related to non-complicated chronic venous insufficiency (CVI), such as sensation of swelling, heaviness and tingling of the legs. Helps to maintain and/or support cardiovascular health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80051330
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging